Erste Asset Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History
Bought
Maintained
Sold
Other funds holding SGMO
WA
Erste Asset Management's SGMO Position: Q3 2024 in Review
Erste Asset Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q3 2024, closing a stake of 38,000 shares — an estimated $15.1K sold.
Erste Asset Management first reported a position in SGMO in Q4 2018 and held it in 23 quarters. The position peaked at $632K in Q4 2020. 103 funds tracked by Wall St. Rank hold SGMO as of Q3 2024.
- Erste Asset Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q3 2024 after selling out during the quarter.
- Erste Asset Management sold 38,000 SANGAMO THERAPEUTICS INC shares in Q3 2024, an estimated $15.1K.
- Erste Asset Management first reported a position in SANGAMO THERAPEUTICS INC in Q4 2018 and held it in 23 quarters.
- Erste Asset Management's SANGAMO THERAPEUTICS INC position peaked at $632K in Q4 2020.
- 103 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q3 2024.
Based on Erste Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.